Are we going to be present at the next CPhI in Frankfurt? We are, of course! For three days, from November 1st to 3rd, we have the opportunity to reaffirm the identity of the company and meet professionals from many different countries. As if it were not enough, we will introduce our last reason of pride: the brand new PolyCrystalLine …
Continue Reading
ABOUT THE CH@BO n.11 ONLINE CONVENTION Because of the uncertainties still associated with the pandemic of SARS-COVID-19 the 11th edition of the Bologna Convention on Crystal Forms CF@Bo n. 11 will take place in online mode. As in the past occasions the meeting will bring together, albeit in virtual mode, academic and industrial experts interested in sharing experience and discussing …
Continue Reading
New Crystalline Forms of Des-Methyl-Venlafaxine Salt Discovered PolyCrystalLine s.r.l. and Segrub Pharmaceuticals have developed a generic equivalent to Pristiq (desvenlafaxine succinate). This DEP001 product is expected to enter the US market at least three years before any other generic desvenlafaxine products enter the market. Pristiq sales are projected to exceed one billion dollars yearly. Pristiq was approved in 2008 by Wyeth Pharmaceuticals for the treatment …
Continue Reading
ABSTRACT: The structure−property relationships of new polymorphs of the chiral herbicide imazamox were investigated by X-ray diffraction, hot stage microscopy (HSM), and differential scanning calorimetry (DSC). Four different polymorphs of imazamox(R) were found. The relationship between different crystal forms, relative thermal stability, and possible conversions pathways was explored. Racemic imazamox, for which no polymorphic modifications could be observed, was also characterized …
Continue Reading
We invite you to join us at our booth n. 4H93 and learn more about our capabilities: Solid Form Development Crystallization Optimization Analytical Services cGMP Manufacturing – PolyCrystalLine CDMO In order to schedule a meeting please contact marco.glucini@polycrystalline.it
Continue Reading
We invite you to join us in our meeting room at the Intercontinental Suite #510/511 and learn more about our capabilities: Solid Form Development Crystallization Optimization Analytical Services In order to schedule a meeting please contact luca.covello@polycrystalline.it.
Continue Reading
PolyCrystalLine received the authorization N°101/2017 from the Italian Ministry of Healthfor the study and chemical/physical analysis of controlled substances. Polycrystalline has invested in capacity, state of the art equipment, and people who have a passion for developing solutions for clients with complex chemistry challenges.
Continue Reading
PolyCrystalLine SpA has been inspected by FDA and received the GMP certification from AIFA for the physico-chemical analyses. For any request please contact us soon.
Continue Reading
Polycrystalline can be entrusted with your most sensitive projects for method development and validation of API’s intermediates, raw materials and finished products. From our experience a shared over-view is what enables effective communication within a group. In order to offer an added value to our clients at Polycrystalline we developed our own web portal for project communication named MyCrystalPro. MyCrystalPro …
Continue Reading
PolyCrystalLine CDMO is on the way.Keep following us for the updates on the progress of our brand new facilities! Next generation of CR-DMO specialized in solid state chemistry! #cdmo #APIs #drugdevelopment #drugdiscovery #chemistry #solidstate #crystallization #drug #pharma #pharmaceutical
Continue Reading